LIKE ALL VIRUSES EXISTING IN THIS WORLD, DOES COVID-19 WILL REMAIN EXIST
FOREVER.
Covid-19 is the disease caused by SARS-COVID-2 virus. This virus has
shown itself to be very contagious with short incubation period in humans. The
pandemic however will end, but you will continue to get sporadic outbreaks
with possibly seasonal patterns. You cannot have reliable vaccines as in small
pox and polio. The covid-19 is a RNA
virus and likes to mutate very comfortably. The worst of its aggression will
tone down after talking the toll of hundreds of thousands of elderly and
twisting the world economy like never before. This may take around six months.
Humans would then learn to live with this virus like a NASTY FLU BUG
which will hit them every season Those with comorbidities’ will continue
to pay heavier price.
In brief, the virus lives in some exotic creatures like cockroaches,
humans are similar when it comes to food habits. In the humans, it found it
very easy to multiply and spread infection largely through contact, the
preventive measure of social distancing, wearing masks and hand washing is
related to this aspect.
The new human host now aggressively leading to morbidity and mortality.
Some mutations take place and more to come across. These mutations can make it
more aggressive or less. The other point is if you kill your host you cannot
survive outside your prey. This is evolutionary and follows the rules of survival.
The covid-virus will not end but humans will learn to live with it by
sacrificing with reduced ability to fight while the majority of the rest will
develop some immunity. Every season we should expect a few thousands to depart
their bodies for years to come. It remains to be seen the hot weather, humidity
and sunshine helps to limit its spread.
Drugs and Vaccines are long way off in terms of cure or prophylaxis;
drugs are likely to help, only up to an extent, once available widely. Rapid
mutations makes vaccines hard to be of great efficiency and hence to be of
great use.
MRC Executive Chair, Professor Fiona Watt, said: Professor Sarah Gilbert putting their
coronavirus vaccine into early-stage clinical trials in humans so quickly.
“The speed at which the
UKRI-funded teams at the University of Oxford and Imperial College London have
developed potential coronavirus vaccines is unprecedented.”
The ChAdOx1 nCoV-19 vaccine is
made from a virus (ChAdOx1), which is a weakened version of a common cold virus
(adenovirus) that causes infections in chimpanzees, that has been genetically
changed so that it is impossible for it to grow in humans.
Genetic material has been added
to the ChAdOx1 construct, that is used to make proteins from the COVID-19 virus
(SARS-CoV-2) called Spike glycoprotein (S). This protein is usually found on
the surface of SARS-CoV-2 and plays an essential role in the infection pathway
of the SARS-CoV-2 virus. The SARS-CoV-2 coronavirus uses its spike protein to
bind to ACE2 receptors on human cells to gain entry to the cells and cause an
infection.
By vaccinating with ChAdOx1
nCoV-19, they are hoping to make the body recognise and develop an immune
response to the Spike protein that will help stop the SARS-CoV-2 virus from
entering human cells and therefore prevent infection.
Vaccines made from the ChAdOx1
virus have been given to more than 320 people to date and have been shown to be
safe and well tolerated, although they can cause temporary side effects, such
as a temperature, headache or sore arm.
This
story is based on content provided by the University of Oxford – read more on their site or find out more
on the vaccine trial
page.
Comments
Post a Comment